This is a multi-part message in MIME format.
------=_NextPart_000_04F6_01C28BFD.C1C4EB90
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Hey AMSA No Phree Lunch/Farmphree phanatics,
Below is an excellent report about patents, WTO and TRIPS. Don't know =
much about the WTO or TRIPS? Then read below. The TRIPS agreement has =
profound implications on access to medicines around the world, including =
AIDS drugs.
Today, I met with students and faculty (from public health, women's =
studies, global studies, etc.) who are currently in the process of =
convincing the U of MN to change its intellectual property policy to =
include an ethical clause on essential medicines, which will have a =
significant effect on U of MN policy regarding research, patents and =
access to essential medicines and may lead to other universities =
following suit. They recently met with some big wigs on campus, VPs and =
VIPs of the University, which yielded some mixed but promising reactions =
from the University leadership regarding the current efforts to change U =
of MN policy.
If you don't know much about essential medicines, check out the =
following excellent Medicins Sans Frontiers website links:
http://www.msf.org/content/page.cfm?articleid=3D82D6EC2B-9E93-4672-9F3697=
B8F8829D36
http://www.accessmed-msf.org/index.asp
The work of this group overlaps with the No Free Lunch/PharmFree initial =
goal discussed at our first meeting last week to seek a U of MN policy =
change to reduce or ban the influence of pharmaceutical representatives =
in University hospitals (as we believe the current policy is at the VA =
hospital). In speaking with the group, they welcomed and hoped for more =
involvement from the medical school, including students, faculty and =
administration as a broad base of support is needed to actually =
implement a policy change as there are many arguments for maintaining =
the status quo. They also said that NFL/PF's policy goal and their =
policy goal could be made in conjunction as they continue to meet with =
policymakers at the U of MN. They plan to meet soon with Frank Cerra. =
Hopefully, we will also be able to meet with our new medical school =
Dean, Deborah Powell and other Deans to gauge their level of interest =
and support. Some 2nd year medical students met with Dean Powell =
yesterday. She seemed poised to make the U of MN medical school a =
leader and innovator of medical education and already identified some =
students who can help make this happen.
A couple members of the group have tentatively agreed to attend our =
World AIDS Day and No Free Lunch/PharmFree meetings next week so they =
can better inform us of their work in progress and discuss ways for us =
to work together. Currently, they are both scheduled for Tuesday, 11/19 =
during lunch. If possible, I think it would be a good idea to change =
the WAD meeting to Monday lunch because there is a lot of overlap of =
people between the two meetings and the HSFC lunch lecture on Somali =
health has been cancelled. We will send an email by tomorrow if we make =
a change in the meeting date. =20
The group has also agreed to present a booth for our WAD commemoration =
on December 2. They also plan/hope to have a symposium on effects of =
international policy property on access to essential medicines in the =
spring, which will invite prominent speakers from other universities =
that also are working to implement similar policy changes. The group =
also recently submitted an editorial to the Daily. I will forward the =
article as soon as I receive it. Many of the group will be leaving =
after this academic year, so they are looking to implement or pave the =
way for changes ASAP. We at the medical school can definitely help make =
this possible.
Fightin' the powers that be,
Quy
Hello. We met at the AMSA meeting on essential medicines. I have been=20
working with a small group of faculty and students to try to get the U =
to=20
change its intellectual property policy to include an ethical clause on=20
essential medicines. We have just finished a series of meetings with=20
administrators, and will be strategizing at our next meeting about =
future=20
direction. You may be interested in attending this. We would certainly =
like your input, and your ideas as to any role AMSA may be willing to =
play=20
in this.
FYI, I am attaching an editorial that we wrote, which was published in =
the=20
Daily in October. Also, I am attaching our list of web references if =
you=20
are interested in reading more background information. I am sure you =
are=20
already familiar with most of it.
Meeting information is as follows:
Thursday, November 14
10:00 a.m.
400 Ford Hall
I hope you can make it. If you cannot, but are interested in being=20
personally involved, or in discussing possibilities for AMSA =
involvement,=20
please let me know.
Cheers,
-Greta
----- Original Message -----=20
From: Marcy Mousavi=20
To: AMSA International Health=20
Sent: Thursday, November 14, 2002 9:16 AM
Subject: [intlhealth] Oxfam report on Pharmaceutical Patents-Summary
Oxfam Briefing Paper No. 33
November 14, 2003
Full report: http://www.oxfam.org/eng/pdfs/pp021112_bullying_patents.pdf
Summary
Last November, developing countries succeeded in getting the World Trade
Organisation (WTO) Ministerial Conference to issue a landmark =
Declaration
stating that public health should take precedence over WTO patent rules.
The so-called Doha Declaration reaffirmed the rights of governments to =
use
WTO public-health safeguards or other measures to gain access to the
cheapest possible medicines, without the threat of trade sanctions or =
the
kindof corporate pressure exerted in Brazil and South Africa earlier =
that year.
One year on, Oxfam has commissioned a review of US government bilateral
policies on patents and medicines to find out how far it has lived up to
these promises. It also looks at the lobbying record of the giant
pharmaceutical companies and s and the
LDCs. To this end, the TRIPS Council should require rich-country members =
to
explain bilateral departures from multilateral standards based on annual
reviews of their bilateral trade policies and agreements, focusing
particularly on the US.
- Rich countries should make export guarantees, tax concessions, and =
other
government incentives conditional on companies respecting the rights of
both developing countries and LDCs to use the TRIPS publichealth
safeguards.
- Investment and pension fund holders should make their funds =
conditional
on companies respecting the rights of both developing countries and LDCs =
to
use the TRIPS public-health safeguards.
- Poor countries should use the longer deadlines for introducing
pharmaceutical patents agreed at Doha, or the TRIPS-compatible =
compulsory
licensing and parallel import provisions, to help increase access to
vitally needed medicines. Additional commitments from the rich countries =
to
the Global Health Fund, bi Yahoo! Web Hosting - Let the expert host your =
site=20
-------------------------------------------------------------------------=
-------
---
You are currently subscribed to intlhealth as: [log in to unmask]
To unsubscribe send a blank email to =
[log in to unmask]
------=_NextPart_000_04F6_01C28BFD.C1C4EB90
Content-Type: text/html;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Diso-8859-1">
<META content=3D"MSHTML 6.00.2719.2200" name=3DGENERATOR>
<STYLE></STYLE>
</HEAD>
<BODY bgColor=3D#ffffff>
<DIV><FONT face=3DArial size=3D2>Hey AMSA No Phree Lunch/Farmphree=20
phanatics,</FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>Below is an excellent report about =
patents, WTO and=20
TRIPS. Don't know much about the WTO or TRIPS? Then read =
below. The TRIPS agreement has profound implications =
on access=20
to medicines around the world, including AIDS drugs.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>Today, I met</FONT> <FONT =
face=3DArial=20
size=3D2>with students and faculty (from public health, women's studies, =
global=20
studies, etc.) who are currently in the process of convincing the U of =
MN to=20
change its intellectual property policy to include an ethical clause on=20
essential medicines, which will have a significant effect on =
</FONT><FONT=20
face=3DArial size=3D2>U of MN policy regarding research, patents and =
access to=20
essential medicines and may lead to other universities following =
suit. =20
They recently met with some big wigs on campus, VPs and VIPs of the=20
University, which yielded some mixed but promising reactions =
from the=20
University leadership regarding the current efforts to change U of =
MN=20
policy.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2>If you don't know much =
about essential=20
medicines, check out the following excellent Medicins Sans Frontiers =
website=20
links:</FONT></DIV>
<DIV><FONT face=3DArial size=3D2><A=20
href=3D"http://www.msf.org/content/page.cfm?articleid=3D82D6EC2B-9E93-467=
2-9F3697B8F8829D36">http://www.msf.org/content/page.cfm?articleid=3D82D6E=
C2B-9E93-4672-9F3697B8F8829D36</A></FONT></DIV>
<DIV><FONT face=3DArial size=3D2><A=20
href=3D"http://www.accessmed-msf.org/index.asp">http://www.accessmed-msf.=
org/index.asp</A></FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>The work of this group overlaps with =
the No Free=20
Lunch/PharmFree initial goal discussed at our first meeting last week to =
seek a=20
U of MN policy change to reduce or ban the influence =
of pharmaceutical=20
representatives in University hospitals (as we believe the current =
policy=20
is at the VA hospital). In speaking with the group, they =
welcomed and=20
hoped for more involvement from the medical school, including students, =
faculty=20
and administration as a broad base of support is needed to actually =
implement a=20
policy change as there are many arguments for maintaining the status =
quo. =20
They also said that NFL/PF's policy goal and their policy goal could be =
made in=20
conjunction as they continue to meet with policymakers at the U of =
MN. =20
They plan to meet soon with Frank Cerra. Hopefully, =
we will also=20
be able to meet with our new medical school Dean, Deborah =
Powell and other=20
Deans to gauge their level of interest and support. Some 2nd =
year=20
medical students met with Dean Powell yesterday. She seemed poised =
to make=20
the U of MN medical school a leader and innovator of medical education =
and=20
already identified some students who can help make this =
happen.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>A couple members of the group have =
tentatively=20
agreed to attend our World AIDS Day and No Free Lunch/PharmFree meetings =
next=20
week so they can better inform us of their work in progress and discuss =
ways for=20
us to work together. Currently, they are both scheduled for =
Tuesday, 11/19=20
during lunch. If possible, I think it would be a good idea to =
change the=20
WAD meeting to Monday lunch because there is a lot of overlap of people =
between=20
the two meetings and the HSFC lunch lecture on Somali health has been=20
cancelled. We will send an email by tomorrow if we make a change =
in the=20
meeting date. </FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>The group has also agreed =
to present a booth=20
for our WAD commemoration on December 2. They also plan/hope to =
have a=20
symposium on effects of international policy property on access to =
essential=20
medicines in the spring, which will invite prominent speakers from other =
universities that also are working to implement similar policy=20
changes. The group also recently submitted an editorial to the=20
Daily. I will forward the article as soon as I receive it. =
Many of=20
the group will be leaving after this academic year, so they are looking =
to=20
implement or pave the way for changes ASAP. We at the medical =
school=20
can definitely help make this possible.</FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>Fightin' the powers that =
be,</FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2>Quy</FONT></DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV>Hello. We met at the AMSA meeting on essential =
medicines. I=20
have been <BR>working with a small group of faculty and students to try =
to get=20
the U to <BR>change its intellectual property policy to include an =
ethical=20
clause on <BR>essential medicines. We have just finished a series =
of=20
meetings with <BR>administrators, and will be strategizing at our next =
meeting=20
about future <BR>direction. You may be interested in attending =
this. =20
We would certainly <BR>like your input, and your ideas as to any role =
AMSA may=20
be willing to play <BR>in this.<BR><BR>FYI, I am attaching an editorial =
that we=20
wrote, which was published in the <BR>Daily in October. Also, I am =
attaching our list of web references if you <BR>are interested in =
reading more=20
background information. I am sure you are <BR>already familiar =
with most=20
of it.<BR><BR>Meeting information is as=20
follows:<BR> Thursday, November=20
14<BR> 10:00=20
a.m.<BR> 400 Ford Hall<BR><BR>I hope you =
can make=20
it. If you cannot, but are interested in being <BR>personally =
involved, or=20
in discussing possibilities for AMSA involvement, <BR>please let me=20
know.<BR><BR>Cheers,<BR>-Greta</DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV><FONT face=3DArial size=3D2></FONT> </DIV>
<DIV style=3D"FONT: 10pt arial">----- Original Message -----=20
<DIV style=3D"BACKGROUND: #e4e4e4; font-color: black"><B>From:</B> <A=20
[log in to unmask]
href=3D"mailto:[log in to unmask]">Marcy Mousavi</A> </DIV>
<DIV><B>To:</B> <A [log in to unmask]
href=3D"mailto:[log in to unmask]">AMSA International Health</A> =
</DIV>
<DIV><B>Sent:</B> Thursday, November 14, 2002 9:16 AM</DIV>
<DIV><B>Subject:</B> [intlhealth] Oxfam report on Pharmaceutical=20
Patents-Summary</DIV></DIV>
<DIV><FONT face=3DArial size=3D2></FONT><FONT face=3DArial =
size=3D2></FONT><FONT=20
face=3DArial size=3D2></FONT><BR></DIV>
<P>Oxfam Briefing Paper No. 33<BR>November 14, 2003<BR>Full report: <A=20
href=3D"http://www.oxfam.org/eng/pdfs/pp021112_bullying_patents.pdf"=20
target=3D_blank>http://www.oxfam.org/eng/pdfs/pp021112_bullying_patents.p=
df</A><BR><BR>Summary<BR>Last=20
November, developing countries succeeded in getting the World=20
Trade<BR>Organisation (WTO) Ministerial Conference to issue a landmark=20
Declaration<BR>stating that public health should take precedence over =
WTO patent=20
rules.<BR>The so-called Doha Declaration reaffirmed the rights of =
governments to=20
use<BR>WTO public-health safeguards or other measures to gain access to=20
the<BR>cheapest possible medicines, without the threat of trade =
sanctions or=20
the<BR>kindof corporate pressure exerted in Brazil and South Africa =
earlier that=20
year.<BR>One year on, Oxfam has commissioned a review of US government=20
bilateral<BR>policies on patents and medicines to find out how far it =
has lived=20
up to<BR>these promises. It also looks at the lobbying record of the=20
giant<BR>pharmaceutical companies and s and the<BR>LDCs. To this end, =
the TRIPS=20
Council should require rich-country members to<BR>explain bilateral =
departures=20
from multilateral standards based on annual<BR>reviews of their =
bilateral trade=20
policies and agreements, focusing<BR>particularly on the US.<BR>- Rich =
countries=20
should make export guarantees, tax concessions, and other<BR>government=20
incentives conditional on companies respecting the rights of<BR>both =
developing=20
countries and LDCs to use the TRIPS publichealth<BR>safeguards.<BR>- =
Investment=20
and pension fund holders should make their funds conditional<BR>on =
companies=20
respecting the rights of both developing countries and LDCs to<BR>use =
the TRIPS=20
public-health safeguards.<BR>- Poor countries should use the longer =
deadlines=20
for introducing<BR>pharmaceutical patents agreed at Doha, or the=20
TRIPS-compatible compulsory<BR>licensing and parallel import provisions, =
to help=20
increase access to<BR>vitally needed medicines. Additional commitments =
from the=20
rich countries to<BR>the Global Health Fund, bi <A=20
href=3D"http://rd.yahoo.com/hosting/mailsig/*http://webhosting.yahoo.com"=
>Yahoo!=20
Web Hosting</A> - Let the expert host your site=20
<P>
<HR>
<P></P>---<BR>You are currently subscribed to intlhealth as:=20
[log in to unmask]<BR>To unsubscribe send a blank email to=20
[log in to unmask]<BR></BODY></HTML>
------=_NextPart_000_04F6_01C28BFD.C1C4EB90--
|
